Norway Crown Princess Lung Transplant
Analysis based on 15 articles · First reported Dec 19, 2025 · Last updated Dec 19, 2025
This event is unlikely to have a direct impact on financial markets as it concerns the health of a royal family member. However, it could indirectly affect public sentiment in Norway, which is not a market-moving factor.
Mette-Marit, Crown Princess of Norway, 52, is expected to undergo a lung transplant due to a significant deterioration in her health. She was diagnosed with pulmonary fibrosis in October 2018, an incurable disease causing lung scarring and shortness of breath. Recent tests in autumn 2025 showed a clear negative development in her condition, prompting preparations for a transplant at Oslo University Hospital. Aare Martin Holm, head of pulmonary medicine at Oslo University Hospital, confirmed that the time for a transplant is approaching, though a date for her placement on the waiting list has not yet been decided. Mette-Marit, Crown Princess of Norway has expressed a strong desire to continue her public duties, with her official program being adapted to her health situation. Haakon, Crown Prince of Norway, has spoken about his wife's struggles, and Jonas Gahr Støre, Prime Minister of Norway, offered his well wishes. The articles also briefly mention that Marius Borg Høiby, Mette-Marit, Crown Princess of Norway's son from a previous relationship, is facing legal charges, but this is unrelated to the main event.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard